Hints and tips:
...The deal is Pfizer’s largest since its 2016 purchase of Medivation for $14.3bn....
...Pfizer declined to comment on pricing, citing confidentiality....
...The oncology-focused biotech agreed a $43bn deal to be acquired by Pfizer....
...through on their mission to draw a tougher line on antitrust.Still outstanding are large contested deals, including Amgen’s planned $28bn takeover of Horizon Therapeutics and Pfizer’s $43bn acquisition...
...Johnson & Johnson announced in November it had struck a deal to acquire cardiovascular technology group Abiomed for $16.6bn, while Pfizer said in May it had agreed to buy US biotech Biohaven Pharmaceuticals...
...The Wall Street Journal first reported that Pfizer was in advanced talks with GBT....
...“As our complaints note, Epic used privacy-invasive default settings and deceptive interfaces that tricked Fortnite users, including teenagers and children,” said FTC chair Lina Khan....
...GlaxoSmithKline and Pfizer are holding out for an improved bid of at least £60bn for their consumer healthcare joint venture, bolstered by shareholder opposition to Unilever’s £50bn offer....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Pfizer, AbbVie and Bristol-Myers Squibb all have blockbuster drugs due to lose exclusivity soon and have recently sealed multibillion-dollar deals....
...EU officials have spent the past week at loggerheads over how to distribute a portion of the 10m Pfizer jab deliveries brought forward from the third quarter....
...mehreen.khan@ft.com; @MehreenKhndavid.hindley@ft.com...
...It needs more doses now — but we also need to be ready for the variants,” said Angela Hwang, president of global biopharma for Pfizer, whose vaccine developed with Germany’s BioNTech was the first to win...
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...The commission last week announced a provisional deal to double its order of the BioNTech/Pfizer drug to 600m doses. “The numbers are there,” she said of overall vaccine supplies....
...Pfizer similarly has all of its non-US production situated inside the bloc....
...mehreen.khan@ft.com; @MehreenKhnmichael.peel@ft.com; @Mikepeeljournodavid.hindley@ft.com...
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Other deals included Bristol-Myers-Squibb’s $74bn takeover of biotech group Celgene and Pfizer’s $11.4bn acquisition of Array BioPharma....
...Read more from DD’s Miles Kruppa and James Fontanella-Khan here. Job moves Germany’s Continental AG appointed company veteran Nikolai Setzer as its chief executive....
...Prime minister Imran Khan announced a moratorium on further coal-fired power plants at the Climate Ambition Summit in December....
...The new Pfizer venture will focus on drugs where exclusivity has expired....
...The US administration has committed to spending $1.95bn on 100m doses of a potential Covid-19 vaccine being developed by Germany’s BioNTech and US pharma giant Pfizer....
...Business groups and think-tanks are making a mistake to cast Uber v London as a totemic fight to preserve capitalism....
International Edition